) associated to spongiform degeneration of the brain 1 . Although rare, CJD is the most common prionic disease in humans with an incidence rate around 1/1,000,000 2 . Historically, it was first described as a dementing illness by Jakob in 1921 [3] [4] [5] . CJD is a rapidly progressive dementia syndrome associated to pyramidal, extrapyramidal and visual signs and symptoms. About 90% of the affected individuals develop movement disorders throughout the course of CJD and myoclonus is the most common disorder seen in 82 to 100% of cases 6 . Other movement disorders less frequently seen include: dystonia, choreoathetosis, tremors, and parkinsonian syndrome. The rate of movement disorders increases as CJD progresses and they are less frequently seen in the early stages of disease. Parkinsonism is rarely found as an early manifestation of CJD 7 . CJD can be classified as sporadic, genetic, iatrogenic and variant form 2, 4, 5, 8 . It is characterized by fast disease progression with a mean survival rate of four months after diagnosis. Two-thirds of patients with CJD die within six months after symptom onset. Some patients at early stages can progress to a state of akinetic mutism 1, 2 . Dementia with Lewy bodies (DLB) is a dementia syndrome associated to parkinsonism with little response to L-DOPA, cognitive fluctuations, visual hallucinations, and hypersensitivity to neuroleptics. It has a slower course but life expectancy is 5 to 8 years after symptom onset. DLB is the second most frequent cause of neurodegenerative dementia and its main differential diagnosis are with Alzheimer' s disease, Parkinson' s disease and some forms of atypical parkinsonism 9, 10 . In vivo diagnostic confirmation for both CJD and DLB is a challenge since the gold standard for their diagnosis is pathology examination 11 . We report a case of CJD that was firstly clinically diagnosed as DLB, highlighting the occurrence of severe parkinsonian syndrome associated to neuroleptic use.
CaSe
A 65-year-old male patient with no clinical comorbidities or relevant family history developed short-term memory loss, episodes of mental confusion, visual hallucinations and inversion of the sleep-awake rhythm that started three months prior to his first medical evaluation. The patient's symptoms progressively aggravated and he was medicated with a neuropletic drug (risperidone 1 mg at night) for controlling behavioral disorders. Three days after the introduction of risperidone the patient developed bilateral symmetrical rigid-akinetic parkinsonian syndrome showing high severity scores (Hoehn & Yahr=4, Unified Parkinson's Disease Rating Scale part III=60, Schwab & England=20%) that made him bedridden and unable to eat independently. He was admitted to the hospital for investigation of his parkinsonian syndrome associated to behavioral-cognitive symptoms and a diagnostic hypothesis of DLB was made. Although risperidone was discontinued and biperiden was given at a dose of up to 16 mg a day, the patient did not show any symptom relief and developed myoclonus in the face and extremities. Serological (HIV, syphilis, hepatitis B and C) and rheumatology tests, and vitamin B12 and folic acid measurements were all normal. Brain magnetic resonance imaging (MRI) showed abnormal signal intensity in putamen and caudate nucleus and in the surface area of cortical gyri bilaterally in FLAIR and diffusion imaging sequences (Fig 1) . The electroencephalogram (EEG) revealed generalized short periodic triphasic wave complexes (Fig 2) and 14-3-3 protein was detected in the cerebrospinal fluid (CSF). Since these findings were all consistent with CJD, the initial diagnosis of DLB was changed.
During his admission the patient progressed with apathy, difficulties with understanding and expression, akinetic mutism and required enteral feeding, tracheostomy and respiratory support.
The patient died seven months after symptom onset due to respiratory complications.
Informed consent to allow data publication was signed by the patient responsible relative.
diSCuSSion
The diagnostic hypothesis of CJD should be suggested in any patient aged between 55 and 65 years with history of rapidly progressive dementia syndrome associated to pyramidal, extrapyramidal, cerebellar or visual symptoms 1 16 . On the other hand, patients with rapidly progressive dementia manifestations associated to parkinsonian symptoms have been misdiagnosed as CJD but subsequently they were confirmed as DLB cases in the pathology examination 17 . DLB has several clinical characteristics in common with CJD such as cognitive deficit, and movement and behavioral disorders 11, 18 . These clinical features may lead to diagnostic confusion at early stages in both diseases and additional exams may be necessary to provide diagnostic confirmation. DLB is diagnosed according to clinical criteria 18 and supported by occipital hypoperfusion on SPECT; a definite diagnosis can only be established by autopsy 9 .
On the other hand, CJD is supported by cerebrospinal fluid findings (positive 14-3-3 protein on CSF), brain magnetic resonance imaging (hyperintensity of the basal ganglia) 19, 20 , but a definite diagnosis can also only be made by autopsy.
Hypersensitivity to neuroleptics leading to or aggravating parkinsonian symptoms is a clinical diagnostic feature of DLB. In the case reported here, the patient had severe manifestations of parkinsonism while taking lowdose risperidone with no relief after its discontinuation. We believe his hypersensitivity was due to preexisting anatomical and functional alterations in the basal nuclei, as shown in Figure 1 , caused by CJD. This hypersensitivity to neuroleptics might be a major factor leading to diagnostic confusion between DLB and CJD as Lemstra et al. 18 pointed out in their study.
In conclusion, there can be diagnostic confusion between DLB and CJD in patients with rapidly progressive dementia syndrome associated to extrapyramidal symptoms, behavioral disorders, and hypersensitivity to neuroleptics. The detection of 14-3-3 protein in CSF, abnormal signal intensity in the basal nuclei in brain MRI and short disease course are findings suggestive of CJD 17, 19, 21, 22 . The finding of a periodic pattern in EEG, although regarded highly sensitive to CJD, can also be seen in patients with DLB 23, 24 and should not be used as a single tool for diagnosis.
